Skip to main content
NCBI home page
The EMBO Journal logoLink to The EMBO Journal
. 1996 Aug 15;15(16):4297–4306.

PAX8-mediated activation of the wt1 tumor suppressor gene.

M Dehbi 1, J Pelletier 1
PMCID: PMC452155  PMID: 8861958

Abstract

The developing renal system has long been exploited to study the regulation of gene expression during mesenchymal-epithelial transitions. Several transcription factors, including WT1 and PAX8, are expressed early in nephrogenesis and play a key role in this process. The expression of PAX8 occurs in the induced mesenchyme of the developing kidney prior to the upregulation of WT1 levels in the same cells. In this report, we assessed whether the Pax-8 gene product resides upstream of wt1 in a common regulatory pathway. Transfection studies, as well as gel-shift assays, indicate that PAX8 transactivates wt1 through elements within a 38 bp conserved motif, present in human and murine promoters. Two PAX8 isoforms, generated by alternative splicing at the C-terminus and previously thought to lack transactivation potential, were found to be capable of activating wt1 expression. We also demonstrate that the endogenous wt1 promoter can be upregulated by exogenously supplied PAX8, suggesting that a function of PAX8 during mesenchymal--epithelial cell transition in renal development is to induce wt1 gene expression.

Full text

PDF
4297

Images in this article

4301Image
on p.4301
4303Image
on p.4303
4303Image
on p.4303
4303Image
on p.4303

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams B., Dörfler P., Aguzzi A., Kozmik Z., Urbánek P., Maurer-Fogy I., Busslinger M. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 1992 Sep;6(9):1589–1607. doi: 10.1101/gad.6.9.1589. [DOI] [PubMed] [Google Scholar]
  2. Auffray C., Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem. 1980 Jun;107(2):303–314. doi: 10.1111/j.1432-1033.1980.tb06030.x. [DOI] [PubMed] [Google Scholar]
  3. Barberis A., Widenhorn K., Vitelli L., Busslinger M. A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. Genes Dev. 1990 May;4(5):849–859. doi: 10.1101/gad.4.5.849. [DOI] [PubMed] [Google Scholar]
  4. Barr F. G., Galili N., Holick J., Biegel J. A., Rovera G., Emanuel B. S. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet. 1993 Feb;3(2):113–117. doi: 10.1038/ng0293-113. [DOI] [PubMed] [Google Scholar]
  5. Beckwith J. B., Kiviat N. B., Bonadio J. F. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol. 1990;10(1-2):1–36. doi: 10.3109/15513819009067094. [DOI] [PubMed] [Google Scholar]
  6. Bopp D., Burri M., Baumgartner S., Frigerio G., Noll M. Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drosophila. Cell. 1986 Dec 26;47(6):1033–1040. doi: 10.1016/0092-8674(86)90818-4. [DOI] [PubMed] [Google Scholar]
  7. Bruening W., Pelletier J. A non-AUG translational initiation event generates novel WT1 isoforms. J Biol Chem. 1996 Apr 12;271(15):8646–8654. doi: 10.1074/jbc.271.15.8646. [DOI] [PubMed] [Google Scholar]
  8. Call K. M., Glaser T., Ito C. Y., Buckler A. J., Pelletier J., Haber D. A., Rose E. A., Kral A., Yeger H., Lewis W. H. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 1990 Feb 9;60(3):509–520. doi: 10.1016/0092-8674(90)90601-a. [DOI] [PubMed] [Google Scholar]
  9. Chalepakis G., Fritsch R., Fickenscher H., Deutsch U., Goulding M., Gruss P. The molecular basis of the undulated/Pax-1 mutation. Cell. 1991 Sep 6;66(5):873–884. doi: 10.1016/0092-8674(91)90434-z. [DOI] [PubMed] [Google Scholar]
  10. Coppes M. J., Liefers G. J., Paul P., Yeger H., Williams B. R. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1416–1419. doi: 10.1073/pnas.90.4.1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Czerny T., Schaffner G., Busslinger M. DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. Genes Dev. 1993 Oct;7(10):2048–2061. doi: 10.1101/gad.7.10.2048. [DOI] [PubMed] [Google Scholar]
  12. Dey B. R., Sukhatme V. P., Roberts A. B., Sporn M. B., Rauscher F. J., 3rd, Kim S. J. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol Endocrinol. 1994 May;8(5):595–602. doi: 10.1210/mend.8.5.8058069. [DOI] [PubMed] [Google Scholar]
  13. Dressler G. R., Douglass E. C. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1179–1183. doi: 10.1073/pnas.89.4.1179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dressler G. R., Wilkinson J. E., Rothenpieler U. W., Patterson L. T., Williams-Simons L., Westphal H. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature. 1993 Mar 4;362(6415):65–67. doi: 10.1038/362065a0. [DOI] [PubMed] [Google Scholar]
  15. Drummond I. A., Madden S. L., Rohwer-Nutter P., Bell G. I., Sukhatme V. P., Rauscher F. J., 3rd Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science. 1992 Jul 31;257(5070):674–678. doi: 10.1126/science.1323141. [DOI] [PubMed] [Google Scholar]
  16. Eccles M. R., Yun K., Reeve A. E., Fidler A. E. Comparative in situ hybridization analysis of PAX2, PAX8, and WT1 gene transcription in human fetal kidney and Wilms' tumors. Am J Pathol. 1995 Jan;146(1):40–45. [PMC free article] [PubMed] [Google Scholar]
  17. Englert C., Hou X., Maheswaran S., Bennett P., Ngwu C., Re G. G., Garvin A. J., Rosner M. R., Haber D. A. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 1995 Oct 2;14(19):4662–4675. doi: 10.1002/j.1460-2075.1995.tb00148.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Epstein J., Cai J., Glaser T., Jepeal L., Maas R. Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. J Biol Chem. 1994 Mar 18;269(11):8355–8361. [PubMed] [Google Scholar]
  19. Fraizer G. C., Wu Y. J., Hewitt S. M., Maity T., Ton C. C., Huff V., Saunders G. F. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter. J Biol Chem. 1994 Mar 25;269(12):8892–8900. [PubMed] [Google Scholar]
  20. Francis-Lang H., Price M., Polycarpou-Schwarz M., Di Lauro R. Cell-type-specific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression. Mol Cell Biol. 1992 Feb;12(2):576–588. doi: 10.1128/mcb.12.2.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fridovich-Keil J. L., Gudas J. M., Bryan I. B., Pardee A. B. Improved expression vectors for eukaryotic promoter/enhancer studies. Biotechniques. 1991 Nov;11(5):572–579. [PubMed] [Google Scholar]
  22. Gashler A. L., Bonthron D. T., Madden S. L., Rauscher F. J., 3rd, Collins T., Sukhatme V. P. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10984–10988. doi: 10.1073/pnas.89.22.10984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gessler M., Poustka A., Cavenee W., Neve R. L., Orkin S. H., Bruns G. A. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990 Feb 22;343(6260):774–778. doi: 10.1038/343774a0. [DOI] [PubMed] [Google Scholar]
  24. Glaser T., Walton D. S., Maas R. L. Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene. Nat Genet. 1992 Nov;2(3):232–239. doi: 10.1038/ng1192-232. [DOI] [PubMed] [Google Scholar]
  25. Goodyer P., Dehbi M., Torban E., Bruening W., Pelletier J. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1. Oncogene. 1995 Mar 16;10(6):1125–1129. [PubMed] [Google Scholar]
  26. Gruss P., Walther C. Pax in development. Cell. 1992 May 29;69(5):719–722. doi: 10.1016/0092-8674(92)90281-g. [DOI] [PubMed] [Google Scholar]
  27. Haber D. A., Sohn R. L., Buckler A. J., Pelletier J., Call K. M., Housman D. E. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9618–9622. doi: 10.1073/pnas.88.21.9618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Harrington M. A., Konicek B., Song A., Xia X. L., Fredericks W. J., Rauscher F. J., 3rd Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J Biol Chem. 1993 Oct 5;268(28):21271–21275. [PubMed] [Google Scholar]
  29. Hofmann W., Royer H. D., Drechsler M., Schneider S., Royer-Pokora B. Characterization of the transcriptional regulatory region of the human WT1 gene. Oncogene. 1993 Nov;8(11):3123–3132. [PubMed] [Google Scholar]
  30. Holst B. D., Goomer R. S., Wood I. C., Edelman G. M., Jones F. S. Binding and activation of the promoter for the neural cell adhesion molecule by Pax-8. J Biol Chem. 1994 Sep 2;269(35):22245–22252. [PubMed] [Google Scholar]
  31. Kozmik Z., Kurzbauer R., Dörfler P., Busslinger M. Alternative splicing of Pax-8 gene transcripts is developmentally regulated and generates isoforms with different transactivation properties. Mol Cell Biol. 1993 Oct;13(10):6024–6035. doi: 10.1128/mcb.13.10.6024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kreidberg J. A., Sariola H., Loring J. M., Maeda M., Pelletier J., Housman D., Jaenisch R. WT-1 is required for early kidney development. Cell. 1993 Aug 27;74(4):679–691. doi: 10.1016/0092-8674(93)90515-r. [DOI] [PubMed] [Google Scholar]
  33. Larsson S. H., Charlieu J. P., Miyagawa K., Engelkamp D., Rassoulzadegan M., Ross A., Cuzin F., van Heyningen V., Hastie N. D. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell. 1995 May 5;81(3):391–401. doi: 10.1016/0092-8674(95)90392-5. [DOI] [PubMed] [Google Scholar]
  34. Little M. H., Prosser J., Condie A., Smith P. J., Van Heyningen V., Hastie N. D. Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4791–4795. doi: 10.1073/pnas.89.11.4791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Maulbecker C. C., Gruss P. The oncogenic potential of Pax genes. EMBO J. 1993 Jun;12(6):2361–2367. doi: 10.1002/j.1460-2075.1993.tb05890.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. McCann S., Sullivan J., Guerra J., Arcinas M., Boxer L. M. Repression of the c-myb gene by WT1 protein in T and B cell lines. J Biol Chem. 1995 Oct 6;270(40):23785–23789. doi: 10.1074/jbc.270.40.23785. [DOI] [PubMed] [Google Scholar]
  37. Mundlos S., Pelletier J., Darveau A., Bachmann M., Winterpacht A., Zabel B. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development. 1993 Dec;119(4):1329–1341. doi: 10.1242/dev.119.4.1329. [DOI] [PubMed] [Google Scholar]
  38. Park S., Bernard A., Bove K. E., Sens D. A., Hazen-Martin D. J., Garvin A. J., Haber D. A. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nat Genet. 1993 Dec;5(4):363–367. doi: 10.1038/ng1293-363. [DOI] [PubMed] [Google Scholar]
  39. Patterson L. T., Dressler G. R. The regulation of kidney development: new insights from an old model. Curr Opin Genet Dev. 1994 Oct;4(5):696–702. doi: 10.1016/0959-437x(94)90136-q. [DOI] [PubMed] [Google Scholar]
  40. Pelletier J., Bruening W., Kashtan C. E., Mauer S. M., Manivel J. C., Striegel J. E., Houghton D. C., Junien C., Habib R., Fouser L. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991 Oct 18;67(2):437–447. doi: 10.1016/0092-8674(91)90194-4. [DOI] [PubMed] [Google Scholar]
  41. Pelletier J., Schalling M., Buckler A. J., Rogers A., Haber D. A., Housman D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 1991 Aug;5(8):1345–1356. doi: 10.1101/gad.5.8.1345. [DOI] [PubMed] [Google Scholar]
  42. Plachov D., Chowdhury K., Walther C., Simon D., Guenet J. L., Gruss P. Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development. 1990 Oct;110(2):643–651. doi: 10.1242/dev.110.2.643. [DOI] [PubMed] [Google Scholar]
  43. Poleev A., Fickenscher H., Mundlos S., Winterpacht A., Zabel B., Fidler A., Gruss P., Plachov D. PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors. Development. 1992 Nov;116(3):611–623. doi: 10.1242/dev.116.3.611. [DOI] [PubMed] [Google Scholar]
  44. Poleev A., Wendler F., Fickenscher H., Zannini M. S., Yaginuma K., Abbott C., Plachov D. Distinct functional properties of three human paired-box-protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumors. Eur J Biochem. 1995 Mar 15;228(3):899–911. doi: 10.1111/j.1432-1033.1995.tb20338.x. [DOI] [PubMed] [Google Scholar]
  45. Pritchard-Jones K., Fleming S., Davidson D., Bickmore W., Porteous D., Gosden C., Bard J., Buckler A., Pelletier J., Housman D. The candidate Wilms' tumour gene is involved in genitourinary development. Nature. 1990 Jul 12;346(6280):194–197. doi: 10.1038/346194a0. [DOI] [PubMed] [Google Scholar]
  46. Rauscher F. J., 3rd, Morris J. F., Tournay O. E., Cook D. M., Curran T. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science. 1990 Nov 30;250(4985):1259–1262. doi: 10.1126/science.2244209. [DOI] [PubMed] [Google Scholar]
  47. Rauscher F. J., 3rd The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J. 1993 Jul;7(10):896–903. [PubMed] [Google Scholar]
  48. Rupprecht H. D., Drummond I. A., Madden S. L., Rauscher F. J., 3rd, Sukhatme V. P. The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem. 1994 Feb 25;269(8):6198–6206. [PubMed] [Google Scholar]
  49. Ryan G., Steele-Perkins V., Morris J. F., Rauscher F. J., 3rd, Dressler G. R. Repression of Pax-2 by WT1 during normal kidney development. Development. 1995 Mar;121(3):867–875. doi: 10.1242/dev.121.3.867. [DOI] [PubMed] [Google Scholar]
  50. Shapiro D. N., Sublett J. E., Li B., Downing J. R., Naeve C. W. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 1993 Nov 1;53(21):5108–5112. [PubMed] [Google Scholar]
  51. Stuart E. T., Haffner R., Oren M., Gruss P. Loss of p53 function through PAX-mediated transcriptional repression. EMBO J. 1995 Nov 15;14(22):5638–5645. doi: 10.1002/j.1460-2075.1995.tb00251.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Tagge E. P., Hanson P., Re G. G., Othersen H. B., Jr, Smith C. D., Garvin A. J. Paired box gene expression in Wilms' tumor. J Pediatr Surg. 1994 Feb;29(2):134–141. doi: 10.1016/0022-3468(94)90308-5. [DOI] [PubMed] [Google Scholar]
  53. Varanasi R., Bardeesy N., Ghahremani M., Petruzzi M. J., Nowak N., Adam M. A., Grundy P., Shows T. B., Pelletier J. Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3554–3558. doi: 10.1073/pnas.91.9.3554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wang Z. Y., Madden S. L., Deuel T. F., Rauscher F. J., 3rd The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem. 1992 Nov 5;267(31):21999–22002. [PubMed] [Google Scholar]
  55. Wang Z. Y., Qiu Q. Q., Gurrieri M., Huang J., Deuel T. F. WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene. 1995 Mar 16;10(6):1243–1247. [PubMed] [Google Scholar]
  56. Weitzman J. B., Pasqualini R., Takada Y., Hemler M. E. The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation. J Biol Chem. 1993 Apr 25;268(12):8651–8657. [PubMed] [Google Scholar]
  57. Werner H., Re G. G., Drummond I. A., Sukhatme V. P., Rauscher F. J., 3rd, Sens D. A., Garvin A. J., LeRoith D., Roberts C. T., Jr Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5828–5832. doi: 10.1073/pnas.90.12.5828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Wu Y., Fraizer G. C., Saunders G. F. GATA-1 transactivates the WT1 hematopoietic specific enhancer. J Biol Chem. 1995 Mar 17;270(11):5944–5949. doi: 10.1074/jbc.270.11.5944. [DOI] [PubMed] [Google Scholar]
  59. Zannini M., Francis-Lang H., Plachov D., Di Lauro R. Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters. Mol Cell Biol. 1992 Sep;12(9):4230–4241. doi: 10.1128/mcb.12.9.4230. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES